20 November 2017
News and Views
Links and Services
The use of beta-blockers is associated with poor survival in patients with cirrhosis and refractory ascites, finds a study in the September issue of Hepatology.
In this study, investigators from Belgium evaluated the effect of beta-blockers on long-term surv
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors